emodin and daunorubicin

emodin has been researched along with daunorubicin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Bulic, B; Mandelkow, E; Pickhardt, M1
Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T1
Hintzpeter, J; Hofman, J; Martin, HJ; Maser, E; Seliger, JM; Wsol, V1
Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM1

Reviews

3 review(s) available for emodin and daunorubicin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
    Journal of medicinal chemistry, 2013, Jun-13, Volume: 56, Issue:11

    Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Humans; Hydrogen Bonding; Models, Molecular; Protein Binding; Protein Conformation; Structure-Activity Relationship; tau Proteins

2013
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer.
    Journal of drug targeting, 2020, Volume: 28, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Drug Delivery Systems; Emodin; Female; Humans; Liposomes; Mice; Neoplasm Invasiveness; Particle Size

2020

Other Studies

2 other study(ies) available for emodin and daunorubicin

ArticleYear
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
    Bioorganic & medicinal chemistry, 2021, 08-15, Volume: 44

    Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones

2021
Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
    Toxicology and applied pharmacology, 2016, Feb-15, Volume: 293

    Topics: Anthraquinones; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Emodin; Humans; Molecular Docking Simulation; Oxidoreductases; Protein Kinase Inhibitors

2016